The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients

BACKGROUND: In addition to morphological and cytogenetic features, acute myeloid leukemias are characterized by mutations that can be used for target-therapy; also the minimal/measurable residual disease (MRD) could be an important prognostic factor. The purpose of this retrospective study was to in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Cell Int
Main Authors: Salehzadeh, Serena, Guerrini, Francesca, Pizzano, Umberto, Grassi, Susanna, Ciabatti, Elena, Iovino, Lorenzo, Buda, Gabriele, Caracciolo, Francesco, Benedetti, Edoardo, Orciuolo, Enrico, Pelosini, Matteo, Consani, Giovanni, Carulli, Giovanni, Metelli, Maria Rita, Martini, Francesca, Mazziotta, Francesco, Mazzantini, Elisa, Rossi, Pietro, Tavarozzi, Rita, Ricci, Federica, Petrini, Mario, Galimberti, Sara
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Primary Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6449954/
https://ncbi.nlm.nih.gov/pubmed/30992690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-0807-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados